摘要
目的:探讨幽门螺杆菌(Hp)胃炎治疗中应用呋喃唑酮联合雷贝拉唑、克拉霉素的临床效果。方法:收治Hp胃炎患者80例,随机平分为两组,对照组给予奥美拉唑三联方案,观察组给予雷贝拉唑联合呋喃唑酮、克拉霉素,比较两组的效果。结果:观察组临床总有效率、Hp根除率分别均高于对照组,差异有统计学意义(P<0.05)。结论:在Hp胃炎治疗中应用呋喃唑酮联合雷贝拉唑、克拉霉素效果较好。
Objective:To study the clinical effect of furazolidone combined with rebeprazole and clarithromycin in thetreatment of patients with Helicobacter pylori(Hp)gastritis.Methods:80 patients with Hp gastritis were selected.They wererandomly divided into the two groups.Patients in the control group were given omeprazole triple regimen,while patients inthe observation group were given rebeprazole combined with furazolidone,clarithromycin,then we compared the effect of thetwo groups.Results:The clinical total effective rate,HP eradication rate in the observation group were higher than those in thecontrol group,and the differences were statistically significant(P < 0.05).Conclusion:The effect of furazolidone combined withrebeprazole and clarithromycin in the treatment of patients with HP gastritis is good.
作者
杨卉灵
Yang Huiling(The People’s Hospital of Xihua County 466600)
出处
《中国社区医师》
2016年第3期31-31,33,共2页
Chinese Community Doctors
关键词
幽门螺杆菌胃炎
呋喃唑酮
雷贝拉唑
克拉霉素
Helicobacter pylori gastritis
Furazolidone
Rebeprazole
Clarithromycin
